scholarly article | Q13442814 |
P50 | author | Domenico Corrado | Q56529119 |
Perry M Elliott | Q63377425 | ||
Riccardo Bariani | Q89896241 | ||
Kalliopi Pilichou | Q116927285 | ||
Anna C Frigo | Q44764874 | ||
Gaetano Thiene | Q29840356 | ||
Barbara Bauce | Q29840367 | ||
Petros Syrris | Q30225443 | ||
P2093 | author name string | Cristina Basso | |
Marco Cason | |||
Rudy Celeghin | |||
Joanna Jager | |||
Maria Bueno Marinas | |||
P2860 | cites work | 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death | Q55983200 |
A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signaling and miRNA dysregulation | Q57283062 | ||
MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations | Q62476607 | ||
Arrhythmogenic right ventricular cardiomyopathy | Q64043862 | ||
Circulating microRNAs as novel biomarkers for dilated cardiomyopathy | Q38440890 | ||
Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy | Q39033320 | ||
Knockdown of Plakophilin 2 Downregulates miR-184 Through CpG Hypermethylation and Suppression of the E2F1 Pathway and Leads to Enhanced Adipogenesis In Vitro. | Q41009800 | ||
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans | Q41412919 | ||
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. | Q44159535 | ||
miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. | Q45944020 | ||
Circulating microRNAs in arrhythmogenic right ventricular cardiomyopathy with ventricular arrhythmia. | Q47737719 | ||
What is an ROC curve? | Q48114277 | ||
Relations between circulating microRNAs (miR-21, miR-26, miR-29, miR-30 and miR-133a), extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy. | Q52954172 | ||
Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. | Q54408211 | ||
The arrhythmogenic cardiomyopathy-specific coding and non-coding transcriptome in human cardiac stromal cells. | Q55457304 | ||
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. | Q55638651 | ||
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1 | Q55670706 | ||
Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients | Q21143782 | ||
Circulating microRNAs, potential biomarkers for drug-induced liver injury | Q24656209 | ||
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure | Q24673535 | ||
Arrhythmogenic cardiomyopathy | Q26753099 | ||
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
microRNAs: tiny regulators with great potential | Q28214699 | ||
MicroRNAs in Cancer | Q29615539 | ||
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). | Q33164685 | ||
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy. | Q33881246 | ||
Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? | Q34395507 | ||
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Q34465792 | ||
Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program | Q34571316 | ||
Right ventricular cardiomyopathy and sudden death in young people | Q34687427 | ||
DIANA-miRPath v3.0: deciphering microRNA function with experimental support | Q35810103 | ||
Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy | Q36088154 | ||
Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarction | Q36511806 | ||
Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy | Q37010626 | ||
The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy. | Q37624877 | ||
MicroRNA and drug resistance | Q37751868 | ||
Circulating microRNAs: Association with disease and potential use as biomarkers | Q37818867 | ||
Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? | Q37981140 | ||
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. | Q38119180 | ||
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases | Q38418005 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | DESeq2 | Q113018293 |
P433 | issue | 4 | |
P921 | main subject | biomarker | Q864574 |
P577 | publication date | 2020-02-24 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy Cohort | |
P478 | volume | 21 |
Search more.